Literature DB >> 28366091

Hallucinations Predict Relapse After Discontinuation of Risperidone in Patients With Alzheimer's Disease and Psychosis or Agitation.

Helen Lavretsky1.   

Abstract

Entities:  

Keywords:  Alzheimer’s Disease; Antipsychotics; Hallucinations

Mesh：

Substances：

Year:  2017        PMID： 28366091      PMCID： PMC5546409          DOI： 10.1176/appi.ajp.2016.16111314

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN： 0002-953X            Impact factor:   18.112


× No keyword cloud information.
  16 in total

Review 1.  Consensus development conference on antipsychotic drugs and obesity and diabetes.

Authors: 
Journal:  Diabetes Care       Date:  2004-02       Impact factor: 19.112

2.  Effectiveness of atypical antipsychotic drugs in patients with Alzheimer's disease.

Authors:  Lon S Schneider; Pierre N Tariot; Karen S Dagerman; Sonia M Davis; John K Hsiao; M Saleem Ismail; Barry D Lebowitz; Constantine G Lyketsos; J Michael Ryan; T Scott Stroup; David L Sultzer; Daniel Weintraub; Jeffrey A Lieberman
Journal:  N Engl J Med       Date:  2006-10-12       Impact factor: 91.245

Review 3.  The effectiveness of atypical antipsychotics for the treatment of aggression and psychosis in Alzheimer's disease.

Authors:  C Ballard; J Waite
Journal:  Cochrane Database Syst Rev       Date:  2006-01-25

4.  Psychosis, agitation, and antipsychotic treatment in dementia.

Authors:  D P Devanand
Journal:  Am J Psychiatry       Date:  2013-09       Impact factor: 18.112

Review 5.  Cerebrovascular accidents in elderly people treated with antipsychotic drugs: a systematic review.

Authors:  Emilio Sacchetti; Cesare Turrina; Paolo Valsecchi
Journal:  Drug Saf       Date:  2010-04-01       Impact factor: 5.606

Review 6.  Withdrawal versus continuation of chronic antipsychotic drugs for behavioural and psychological symptoms in older people with dementia.

Authors:  Tom Declercq; Mirko Petrovic; Majda Azermai; Robert Vander Stichele; An I M De Sutter; Mieke L van Driel; Thierry Christiaens
Journal:  Cochrane Database Syst Rev       Date:  2013-03-28

7.  The course of neuropsychiatric symptoms in nursing-home patients with dementia over a 53-month follow-up period.

Authors:  Geir Selbaek; Knut Engedal; Jūratė Šaltytė Benth; Sverre Bergh
Journal:  Int Psychogeriatr       Date:  2013-09-23       Impact factor: 3.878

8.  Relapse risk after discontinuation of risperidone in Alzheimer's disease.

Authors:  D P Devanand; Jacobo Mintzer; Susan K Schultz; Howard F Andrews; David L Sultzer; Danilo de la Pena; Sanjay Gupta; Sylvia Colon; Corbett Schimming; Gregory H Pelton; Bruce Levin
Journal:  N Engl J Med       Date:  2012-10-18       Impact factor: 91.245

Review 9.  Tardive dyskinesia rates with atypical antipsychotics in older adults.

Authors:  Dilip V Jeste
Journal:  J Clin Psychiatry       Date:  2004       Impact factor: 4.384

Review 10.  ACNP White Paper: update on use of antipsychotic drugs in elderly persons with dementia.

Authors:  Dilip V Jeste; Dan Blazer; Daniel Casey; Thomas Meeks; Carl Salzman; Lon Schneider; Pierre Tariot; Kristine Yaffe
Journal:  Neuropsychopharmacology       Date:  2007-07-18       Impact factor: 7.853
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.